‹ All Posts
Saurabh Tyagi--Clovek,Advisory

14th Jun 2025 · SEBI-Registered Analyst

SUNPHARMA

US FDA conducted GMP inspection at

SUNPHARMA
Halol facility, issuing a Form-483 with 8 observations.

#FundamentalViews#StockInNews#MacroViews#EquityResearch
219 likes·68 comments